These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26813954)

  • 1. Kidney cancer: When worlds collide--integrating metabolic and transcriptomic data in ccRCC.
    Thoma C
    Nat Rev Urol; 2016 Mar; 13(3):126. PubMed ID: 26813954
    [No Abstract]   [Full Text] [Related]  

  • 2. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.
    Hakimi AA; Reznik E; Lee CH; Creighton CJ; Brannon AR; Luna A; Aksoy BA; Liu EM; Shen R; Lee W; Chen Y; Stirdivant SM; Russo P; Chen YB; Tickoo SK; Reuter VE; Cheng EH; Sander C; Hsieh JJ
    Cancer Cell; 2016 Jan; 29(1):104-116. PubMed ID: 26766592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future prognostic factors for renal cell carcinoma: Workgroup No. 5. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
    Swanson DA; Rothenberg HJ; Boynton AL; Consigliere D; Halling KC; Oda H; Smith D
    Cancer; 1997 Sep; 80(5):997-8. PubMed ID: 9307207
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
    Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney cancer: DA transporter a ccRCC biomarker?
    Fenner A
    Nat Rev Urol; 2016 Nov; 13(11):629. PubMed ID: 27725638
    [No Abstract]   [Full Text] [Related]  

  • 7. Facial fibrofolliculomas as indicator for renal cell cancer.
    Johannesma PC; Starink TM; Van Moorselaar RJ; Postmus PE
    Jpn J Clin Oncol; 2014 Jun; 44(6):609-10. PubMed ID: 24864271
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
    Guan L; Tan J; Li H; Jin X
    Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of
    Yang CA; Huang HY; Yen JC; Chang JG
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma.
    Douglas ML; Richardson MM; Nicol DL
    Cancer; 2004 May; 100(10):2118-24. PubMed ID: 15139053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.
    Cuadros T; Trilla E; Sarró E; Vilà MR; Vilardell J; de Torres I; Salcedo M; López-Hellin J; Sánchez A; Ramón y Cajal S; Itarte E; Morote J; Meseguer A
    Cancer Res; 2014 Mar; 74(5):1416-28. PubMed ID: 24390735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression.
    Wang J; Xi J; Zhang H; Li J; Xia Y; Xi R; Xi Z
    Cancer Commun (Lond); 2019 Jun; 39(1):37. PubMed ID: 31227023
    [No Abstract]   [Full Text] [Related]  

  • 15. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 and 2 papillary renal cancers are genetically distinct.
    Balakrishnan VS
    Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses.
    Seliger B; Lichtenfels R; Kellner R
    Brief Funct Genomic Proteomic; 2003 Oct; 2(3):194-212. PubMed ID: 15239923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
    Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
    Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing.
    Eikrem OS; Strauss P; Beisland C; Scherer A; Landolt L; Flatberg A; Leh S; Beisvag V; Skogstrand T; Hjelle K; Shresta A; Marti HP
    Scand J Urol; 2016 Dec; 50(6):452-462. PubMed ID: 27739342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.